Jade Biosciences (JBIO) Short-term Investments (2021 - 2026)

Jade Biosciences' Short-term Investments history runs 6 years deep, the most recent figure standing at $256.2 million for Q1 2026.

• Quarterly Short-term Investments rose 700.91% year-over-year to $256.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $256.2 million (up 700.91% YoY) and the FY2025 annual result came in at $247.7 million, changed N/A from the prior year.
• Short-term Investments was $256.2 million for Q1 2026 at Jade Biosciences, up from $247.7 million in the prior quarter.
• Across five years, Short-term Investments topped out at $256.2 million in Q1 2026 and bottomed at $32.0 million in Q1 2025.
• A 5-year average of $112.1 million and a median of $98.9 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2025 — Short-term Investments plunged 64.54% — and 2026, when it soared 700.91%.
• Jade Biosciences' Short-term Investments stood at $106.8 million in 2022, then dropped by 7.37% to $98.9 million in 2023, then slumped by 41.77% to $57.6 million in 2024, then jumped by 329.96% to $247.7 million in 2025, then climbed by 3.43% to $256.2 million in 2026.
• Business Quant data shows JBIO's Short-term Investments at $256.2 million in Q1 2026, $247.7 million in Q4 2025, and $148.8 million in Q3 2025.